Articles related to INFLUENZA

Recent studies have indicated a potential increase in stroke risk among seniors, particularly those aged 85 and older, who receive both COVID-19 and influenza vaccines simultaneously. This finding has sparked a renewed focus on the safety of administering multiple vaccines at the same time.

The recent phase 1/2 study of Pfizer-BioNTech’s combination vaccine candidate demonstrated robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains. This promising development could significantly impact global immunization practices.

Addressing racial and ethnic disparities in flu vaccination is not just a public health issue; it’s a matter of social justice. Learn how you can be part of the solution.

Physicians should encourage all patients 6 months of age and older to get vaccinated against influenza this season, regardless of egg allergy. The ACIP’s updated guidance is based on the latest scientific evidence and is designed to help protect patients from influenza.

A chart review of 81 million individuals yielded two matched groups of more than 150,000 patients each: one with COVID and the other with influenza. In these populations, the risk of seizures and epilepsy was higher in the COVID group. The HR of epilepsy after COVID compared with influenza was highest in individuals who were not hospitalized and in those under the age of 16.

The researchers put a theory to the test by administering the compound CBL0137 to melanoma mouse models. This compound causes the same type of highly inflammatory cell death that the influenza virus causes, but it does so directly in cancerous tissue. The resulting antiviral response alerted the immune system. It heated up a “cold” tumor so that, when combined with immunotherapy, the host immune system recognized cancer as something to be destroyed.